555.74 USD
+8.96
1.64%
At close Apr 25, 4:00 PM EDT
After hours
555.74
+0.00
0.00%
1 day
1.64%
5 days
-4.44%
1 month
-8.79%
3 months
-3.31%
6 months
-7.83%
Year to date
5.26%
1 year
-3.07%
5 years
21.65%
10 years
349.45%
 

About: Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Employees: 15,695

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

322% more call options, than puts

Call options by funds: $14.3M | Put options by funds: $3.39M

15% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 55

0% more funds holding

Funds holding: 523 [Q3] → 525 (+2) [Q4]

0.34% more ownership

Funds ownership: 92.34% [Q3] → 92.67% (+0.34%) [Q4]

12% less capital invested

Capital invested by funds: $8.36B [Q3] → $7.35B (-$1B) [Q4]

24% less repeat investments, than reductions

Existing positions increased: 162 | Existing positions reduced: 213

60% less funds holding in top 10

Funds holding in top 10: 5 [Q3] → 2 (-3) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$667
20%
upside
Avg. target
$667
20%
upside
High target
$667
20%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
RBC Capital
Ben Hendrix
34% 1-year accuracy
23 / 67 met price target
20%upside
$667
Outperform
Maintained
14 Mar 2025

Financial journalist opinion

Based on 7 articles about CHE published over the past 30 days

Positive
Zacks Investment Research
13 hours ago
CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines
Chemed delivers first-quarter top-line growth across two of its segments, VITAS and Roto-Rooter.
CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines
Neutral
Seeking Alpha
1 day ago
Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q1 2025 Earnings Conference Call April 24, 2025 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and CEO Mike Witzeman - CFO Nick Westfall - Chairman and CEO, Chemed VITAS Healthcare Corporation Conference Call Participants Ben Hendrix - RBC Capital Markets Operator Good day, and thank you for standing by. Welcome to the Chemed Corporation First Quarter 2025 Earnings Conference Call.
Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript
Positive
Zacks Investment Research
2 days ago
Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $5.63 per share, beating the Zacks Consensus Estimate of $5.60 per share. This compares to earnings of $5.20 per share a year ago.
Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates
Neutral
Business Wire
2 days ago
Chemed Reports First-Quarter 2025 Results
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2025, versus the comparable prior-year period. Results for Quarter Ended March 31, 2025 Consolidated operating results: Revenue increased 9.
Chemed Reports First-Quarter 2025 Results
Positive
Zacks Investment Research
1 week ago
OPCH or CHE: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
OPCH or CHE: Which Is the Better Value Stock Right Now?
Neutral
Business Wire
3 weeks ago
Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 24, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through.
Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
Positive
Zacks Investment Research
4 weeks ago
Why Is Chemed (CHE) Up 4.5% Since Last Earnings Report?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Why Is Chemed (CHE) Up 4.5% Since Last Earnings Report?
Positive
Zacks Investment Research
1 month ago
OPCH vs. CHE: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
OPCH vs. CHE: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
1 month ago
OPCH or CHE: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks is more attractive to value investors?
OPCH or CHE: Which Is the Better Value Stock Right Now?
Neutral
Business Wire
1 month ago
Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 35th Annual Healthcare Conference on Monday, March 17, 2025, at approximately 9:20 a.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be acce.
Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
Charts implemented using Lightweight Charts™